Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Bhupesh Guleria"'
Autor:
Bhupesh Guleria, S. Viswanath, Dharmesh Soneji, Rajan Kapoor, Prerna Guleria, P. Suresh, Manish Kumar, Amol Patel, Shivshankar Swamy
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 01, Pp 073-081 (2022)
Abstract Bhupesh Guleria Aims Adolescent and young adults (AYAs), children with cancer, and their guardians have unique psychosocial morbidities adversely effecting quality of life (QOL). This is measurable using patented tools. We analyzed epidemi
Externí odkaz:
https://doaj.org/article/17f724a541034be8a31347cdd1e26264
Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India—A Survey Report
Autor:
Amol Patel, Vineet Govinda Gupta, Bhupesh Guleria, Chandan K. Das, Prashant Mehta, Kaushik Mahadevapura Ramegowda
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 01, Pp 009-013 (2022)
Abstract Amol Patel Background In India, breast cancer patients' post-treatment follow-up practices are not known. We did this survey to understand how the breast cancer patients are followed-up and tried to explore the challenges associated with i
Externí odkaz:
https://doaj.org/article/b768ee27c22f4483893a395f9dcc1ead
Publikováno v:
Autopsy and Case Reports, Vol 12 (2022)
Solid Papillary Carcinoma (SPC) of the breast is a rare tumor with an incidence of less than 1%, mainly affecting elderly females. It is morphologically characterized by well-defined nodules with low-grade nuclear features associated with fibrovascul
Externí odkaz:
https://doaj.org/article/6df60179ad754185948ced4d8e3d087c
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 64, Iss 1, Pp 140-144 (2021)
Externí odkaz:
https://doaj.org/article/5ca2f19fa0a646a98d22e89681c0985c
Autor:
Amol Patel, Dharmesh Soneji, Harinder Pal Singh, Manish Kumar, Arnab Bandyopadhyay, Ankit Mathur, Anuj Sharma, Gaurav Prakash Singh Gahlot, Shivashankara MS, Bhupesh Guleria, Rajesh Nair, Dipen Bhuva, Suresh Pandalanghat
Publikováno v:
South Asian Journal of Cancer, Vol 9, Iss 02, Pp 074-079 (2020)
Background Prognosis of gallbladder cancer (GBC) has not changed in the past 20 years. Comprehensive genomic profiling (CGP) carries potential to determine the actionability for multiple targets, including ERBB2, ERBB3, MET, ROSI, FGFR, and PIK3. Thi
Externí odkaz:
https://doaj.org/article/9318281cb6dd4c24a3c0168cbcf8cd6b
Publikováno v:
Lung India, Vol 37, Iss 2, Pp 145-150 (2020)
Objectives: The aim of this study is to evaluate the incidence of programmed cell death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) cases and its correlation with gene mutation and clinicopathological parameters. Methods: Sample
Externí odkaz:
https://doaj.org/article/530ace4491fa4e4f90500e573e8ea051
Autor:
Ankit Mathur, A. Bandyopadhyay, Bhupesh Guleria, Manish Kumar, Harinder Singh, Amol Patel, Gaurav Prakash Singh Gahlot, Suresh Pandalanghat, Dharmesh Soneji, Dipen Bhuva, Anuj Sharma, R. U. Nair, Shivashankara Ms
Publikováno v:
South Asian Journal of Cancer, Vol 9, Iss 02, Pp 074-079 (2020)
South Asian Journal of Cancer
South Asian Journal of Cancer
Background Prognosis of gallbladder cancer (GBC) has not changed in the past 20 years. Comprehensive genomic profiling (CGP) carries potential to determine the actionability for multiple targets, including ERBB2, ERBB3, MET, ROSI, FGFR, and PIK3. Thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57a0c97f7f71c110e37b06b8800fa9da
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721180
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721180
Publikováno v:
Lung India. 39:479
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42c4bb97b20e58e857307fa49e925974
https://doi.org/10.4103/lungindia.lungindia_5_22
https://doi.org/10.4103/lungindia.lungindia_5_22
Autor:
Abhishek K. Pathak, Prince Arvind, Subhash Ranjan, Anvesh Rathore, Rahul Sud, P Nikhil, Bhupesh Guleria, Tejas Pandaya, Virendra Singh, Shivshankara
Publikováno v:
Journal of Cancer Research and Therapeutics. 18:428
Metastatic gallbladder cancer (GBC) is a highly fatal malignancy and it is difficult to treat the advanced stage of GBC. In India, northern and northeastern states are the worst affected by this disease. We, hereby, report the clinicoepidemiological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc24cb06066815a6e1fc1b1bdda4bf8d
https://doi.org/10.4103/jcrt.jcrt_1213_20
https://doi.org/10.4103/jcrt.jcrt_1213_20
Autor:
Suresh Pandalanghat, Hitendra Prakash Singh, Shivashankara Swamy Mathighatta Shivarudraiah, Amol Patel, Bhupesh Guleria, Manish Kumar
Publikováno v:
Journal of Clinical Oncology. 38:e16628-e16628
e16628 Background: Rarity in western countries precluded Gallbladder cancer (GBC) from prospective research. Comprehensive Genomic profiling carries potential to determine oncogenic pathways, driver mutations and possible resistance mechanisms. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::477aeb2b183eb8377fb43d7414d54ba9
https://doi.org/10.1200/jco.2020.38.15_suppl.e16628
https://doi.org/10.1200/jco.2020.38.15_suppl.e16628